Welcome to our Liver Cancer Connect Program


webinar series

newly diagnosed

1. LiverCancerStudy Twitter22222

Liver Cancer Connect is a dedicated program of the Hepatitis B Foundation that was created to provide individuals and families with the information and support they need when facing the challenge of primary liver cancer. Although this is a serious diagnosis, there is good reason to have hope because of the many advances made in the early detection, management and treatment of liver cancer.

October is Liver Cancer Awareness Month! Learn how you can get involved!

In the News

H3 Biomedicine Granted Orphan Drug Designation of H3B-6527 for Treatment of Hepatocellular Carcinoma

Lenvatinib application for advanced hepatocellular carcinoma accepted by FDA, which is expected to make a decision in 10 months

Bristol-Myers Squibb’s Opdivo® (nivolumab) Receives FDA Approval for the Treatment of Hepatocellular Carcinoma Patients Previously Treated with Sorafenib

Get Connected

square facebook 512Twitter icon horizontal2